Healthy volunteers help Fine-Tune new COVID-19 pill
NCT ID NCT06945276
First seen May 19, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tested a new tablet form of the experimental COVID-19 drug ALG-097558 in 51 healthy adults. Researchers checked how the drug interacts with other medications and whether food changes how it works. The goal is to gather safety and dosing information, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.